menu
    • menu

    Company profile for Kindos Pharmaceuticals

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Jianjin Pharmaceutical Co., Ltd. faces global regulatory markets such as China, the United States, and Europe. It is constructed and operated based on the current quality standards of the US FDA and China's NMPA and international high safety standards. It is the first batch of sterile injection enterprises in China that have passed the FDA certification as a whole, and is a national high-tech enterprise. We focus on the R&D a...
    Jianjin Pharmaceutical Co., Ltd. faces global regulatory markets such as China, the United States, and Europe. It is constructed and operated based on the current quality standards of the US FDA and China's NMPA and international high safety standards. It is the first batch of sterile injection enterprises in China that have passed the FDA certification as a whole, and is a national high-tech enterprise. We focus on the R&D and commercialization of small-molecule chemical drugs, antibody drugs, new drug delivery systems, nucleic acid-based macromolecular biological drugs and new vaccines. Our independent research and development

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kindos PharmaceuticalsChina Flag
    Country
    Country
    China
    Address
    Address
    No. 8, No. 9, Kexin Road, Comprehensive Bonded Zone, High-tech West District, ...
    Telephone
    Telephone
    +86 15882450824
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kindospharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kindos`s Generics Fluorouracil Receives Approval in US
    Kindos`s Generics Fluorouracil Receives Approval in US

    24 Sep 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216494

    FDA
    24 Sep 2024
    Share Share
    Kindos' Generic Leucovorin Calcium Receives Approval in the U.S.
    Kindos' Generic Leucovorin Calcium Receives Approval in the U.S.

    19 Jul 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216590

    FDA
    19 Jul 2023
    Share Share
    Kindos' Generic Bendamustine Hydrochloride Receives Approval in the U.S.
    Kindos' Generic Bendamustine Hydrochloride Receives Approval in the U.S.

    05 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211001

    FDA
    05 Jun 2023
    Share Share
    Kindos' Generic Nelarabine Receives Approval in the U.S.
    Kindos' Generic Nelarabine Receives Approval in the U.S.

    10 Jan 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216038

    FDA
    10 Jan 2023
    Share Share
    Kindos' Generic Plerixafor Receives Approval in the U.S.
    Kindos' Generic Plerixafor Receives Approval in the U.S.

    15 Dec 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215698

    FDA
    15 Dec 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search